Changes of lymphocyte and subsets counts and the correlation to the prognosis in COVID-19 patients

Q4 Medicine
Xiaomei Yu, Wenbo He, Jiali Zhou, Yating Wang, Lang Wang
{"title":"Changes of lymphocyte and subsets counts and the correlation to the prognosis in COVID-19 patients","authors":"Xiaomei Yu, Wenbo He, Jiali Zhou, Yating Wang, Lang Wang","doi":"10.14188/J.1671-8852.2020.0198","DOIUrl":null,"url":null,"abstract":"Objective: To explore the changes of lymphocyte and subsets counts and their correlations with the prognosis in patients with coronavirus disease 2019 (COVID-19). Methods: A total of 151 COVID-19 patients who were diagnosed and hospitalized in our hospital, and were divided into survival group (n=128, including the discharged and the hospitalized patients) and death group (n=23) according to the outcomes five weeks after admission. The clinical features and the counts of peripheral lymphocyte and subsets were compared between the two groups. Univariate and multivariate Logistic regression were used to evaluate the prognostic roles of peripheral lymphocyte and subsets counts, and the predictive values of them were further determined by ROC curve. Results: Compared with thsoe in survival group, lymphocyte and subsets (CD3+, CD4+, CD8+, and CD19+ cell) counts were significantly lower in death group (all P<0.05). Counts of the lymphocyte were an independent predictor of prognosis. The AUC of lymphocyte and CD3+, CD4+, CD8+, CD19+ cell counts on the basis of the ROC curve were 0.750, 0.711, 0.735, 0.674, and 0.666, respectively (P<0.05). Conclusion: Lymphocyte count is an independent predictor of the prognosis in COVID-19 patients. Increased count of lymphocyte predicts better outcomes. The predictive values for COVID-19 prognosis by lymphocytes, CD3+, and CD4+ cells counts were existed. © 2021, Editorial Board of Medical Journal of Wuhan University. All right reserved.","PeriodicalId":35402,"journal":{"name":"武汉大学学报(医学版)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"武汉大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14188/J.1671-8852.2020.0198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To explore the changes of lymphocyte and subsets counts and their correlations with the prognosis in patients with coronavirus disease 2019 (COVID-19). Methods: A total of 151 COVID-19 patients who were diagnosed and hospitalized in our hospital, and were divided into survival group (n=128, including the discharged and the hospitalized patients) and death group (n=23) according to the outcomes five weeks after admission. The clinical features and the counts of peripheral lymphocyte and subsets were compared between the two groups. Univariate and multivariate Logistic regression were used to evaluate the prognostic roles of peripheral lymphocyte and subsets counts, and the predictive values of them were further determined by ROC curve. Results: Compared with thsoe in survival group, lymphocyte and subsets (CD3+, CD4+, CD8+, and CD19+ cell) counts were significantly lower in death group (all P<0.05). Counts of the lymphocyte were an independent predictor of prognosis. The AUC of lymphocyte and CD3+, CD4+, CD8+, CD19+ cell counts on the basis of the ROC curve were 0.750, 0.711, 0.735, 0.674, and 0.666, respectively (P<0.05). Conclusion: Lymphocyte count is an independent predictor of the prognosis in COVID-19 patients. Increased count of lymphocyte predicts better outcomes. The predictive values for COVID-19 prognosis by lymphocytes, CD3+, and CD4+ cells counts were existed. © 2021, Editorial Board of Medical Journal of Wuhan University. All right reserved.
COVID-19患者淋巴细胞和亚群计数变化及其与预后的关系
目的:探讨2019冠状病毒病(COVID-19)患者淋巴细胞和亚群计数的变化及其与预后的关系。方法:将我院确诊住院的新冠肺炎患者151例,根据入院后5周的预后分为生存组(n=128,包括出院和住院患者)和死亡组(n=23)。比较两组患者的临床特征及外周血淋巴细胞及亚群计数。采用单因素和多因素Logistic回归评估外周血淋巴细胞和亚群计数对预后的影响,并通过ROC曲线进一步确定其预测价值。结果:与生存组比较,死亡组淋巴细胞及亚群(CD3+、CD4+、CD8+、CD19+细胞)计数均显著降低(P<0.05)。淋巴细胞计数是预测预后的独立指标。基于ROC曲线的淋巴细胞及CD3+、CD4+、CD8+、CD19+细胞计数AUC分别为0.750、0.711、0.735、0.674、0.666 (P<0.05)。结论:淋巴细胞计数是新冠肺炎患者预后的独立预测因子。淋巴细胞计数增加预示着更好的预后。淋巴细胞计数、CD3+计数和CD4+计数对COVID-19预后有预测价值。©2021,武汉大学医学杂志编辑委员会。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
武汉大学学报(医学版)
武汉大学学报(医学版) Medicine-Medicine (all)
CiteScore
0.30
自引率
0.00%
发文量
7289
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信